Monsanto Co. (NYSE:MON) Director Charles S. Mcmillan acquired 3,500 shares of the firm’s stock in a transaction on Monday, October 10th. The stock was purchased at an average price of $103.23 per share, with a total value of $361,305.00. Following the acquisition, the director now owns 64,009 shares of the company’s stock, valued at approximately $6,607,649.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Monsanto Co. (NYSE:MON) opened at 102.11 on Monday. The stock has a market capitalization of $44.69 billion, a PE ratio of 34.17 and a beta of 1.19. The firm has a 50-day moving average price of $104.39 and a 200 day moving average price of $101.78. Monsanto Co. has a 12 month low of $83.73 and a 12 month high of $114.26.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted ($0.19) EPS. Equities analysts anticipate that Monsanto Co. will post $4.89 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is currently 71.05%.
Several equities analysts have recently weighed in on the company. S&P Equity Research restated a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. JPMorgan Chase & Co. restated a “hold” rating on shares of Monsanto in a report on Thursday, June 30th. Monness Crespi & Hardt reduced their price target on Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a report on Monday, October 3rd. Zacks Investment Research downgraded Monsanto from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Finally, Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price target for the company in a report on Wednesday, August 3rd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $114.65.
Several large investors have recently modified their holdings of the company. Charter Trust Co. boosted its stake in shares of Monsanto by 0.6% in the third quarter. Charter Trust Co. now owns 10,605 shares of the company’s stock worth $1,084,000 after buying an additional 65 shares during the period. Pennsylvania Trust Co boosted its stake in shares of Monsanto by 0.8% in the third quarter. Pennsylvania Trust Co now owns 7,355 shares of the company’s stock worth $752,000 after buying an additional 55 shares during the period. Callahan Advisors LLC boosted its stake in shares of Monsanto by 77.9% in the third quarter. Callahan Advisors LLC now owns 15,209 shares of the company’s stock worth $1,554,000 after buying an additional 6,662 shares during the period. National Pension Service boosted its stake in shares of Monsanto by 8.6% in the third quarter. National Pension Service now owns 287,008 shares of the company’s stock worth $29,332,000 after buying an additional 22,777 shares during the period. Finally, Private Trust Co. NA boosted its stake in shares of Monsanto by 2.5% in the third quarter. Private Trust Co. NA now owns 8,737 shares of the company’s stock worth $892,000 after buying an additional 216 shares during the period. Hedge funds and other institutional investors own 78.94% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.